Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Nasal calcitonin reduces spinal fractures in postmenopausal women with osteoporosis

Sep. 17, 1998

Novo files for U.S. marketing approval of insulin analogue

Sep. 17, 1998

Late-stage clinical trials of Oralin to begin in Canada

Sep. 17, 1998

Canadian launch for minimally invasive impotence treatment

Sep. 17, 1998

RPR will introduce CombiPatch in U.S. during third quarter

Sep. 16, 1998

European-wide approval for Viagra

Sep. 16, 1998

SKB selects V-ATPase inhibitor SB-242784 for further evaluation

Sep. 16, 1998

Joint venture for development of MPS I treatment now a reality

Sep. 16, 1998

Novel glucagon receptor antagonist with potential in treating type I/type II diabetes

Sep. 15, 1998

Amgen describes preparation and use of KGF proteins

Sep. 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...